Clinical Trial Update: Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 NiCOL trial evaluates nivolumab with radiotherapy and cisplatin for locally advanced cervical cancer, followed by up to 6 months of adjuvant nivolumab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• nivolumab (nivolumab)

Snippet

Sponsor: Institut Curie | Conditions: Cervical Cancer, Locally Advanced Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED